<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03805100</url>
  </required_header>
  <id_info>
    <org_study_id>XBR1001</org_study_id>
    <nct_id>NCT03805100</nct_id>
  </id_info>
  <brief_title>Comparing the Efficacy and Safety of Biosimilar Candidate Xlucane Versus Lucentis® in Patients With nAMD</brief_title>
  <acronym>XPLORE</acronym>
  <official_title>A Phase III Double-Blind, Parallel Group, Multicenter Study to Compare the Efficacy and Safety of Xlucane Versus Lucentis® in Patients With Neovascular Age-Related Macular Degeneration</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xbrane Biopharma AB</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stada Arzneimittel AG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Xbrane Biopharma AB</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives of the study are to demonstrate the equivalence of Xlucane to Lucentis® in
      treatment of subjects with wet (ie, neovascular) age-related macular degeneration (wAMD).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a phase III multicenter, double-masked, randomized, parallel group study in subjects
      with wAMD. Approximately 580 subjects will be enrolled and randomized in a 1:1 ratio to
      receive either Lucentis® or the investigational product, Xlucane in the study eye once every
      4 weeks for 52 weeks. The study eye will be defined as the eye meeting the enrollment
      criteria. The assigned study drug will be administered as an ophthalmic intravitreal (IVT)
      injection. A subgroup of 60 subjects at a select number of participating sites will be
      sequentially asked to participate in an evaluation of PK.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 19, 2019</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Best Corrected Visual Acuity (BCVA)</measure>
    <time_frame>Week 8</time_frame>
    <description>Change(s) in BCVA letters at Week 8 compared to baseline using the ETDRS protocol</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Best Corrected Visual Acuity (BCVA)</measure>
    <time_frame>Week 4, 12, 16, 24, 36 and 52</time_frame>
    <description>Change in BCVA using the ETDRS protocol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in total size of choroidal neovascular leakage area</measure>
    <time_frame>Week 24 and 52</time_frame>
    <description>Change in total size of choroidal neovascular leakage area measured by fluorescein angiography (FA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in total size of choroidal neovascularization</measure>
    <time_frame>Week 24 and 52</time_frame>
    <description>Change in total size of choroidal neovascularization measured by FA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Central Foveal Thickness (CFT)</measure>
    <time_frame>Week 2, 4, 8, 16, 24, 36 and 52</time_frame>
    <description>Change in Central Foveal Thickness (CFT) measured by OCT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of subjects with loss of &lt; 15 letters</measure>
    <time_frame>Week 4, 8, 24 and 52</time_frame>
    <description>Percentage of subjects with loss of &lt; 15 letters using ETDRS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of subjects with a gain of ≥ 15 letters</measure>
    <time_frame>Week 4, 8, 24 and 52</time_frame>
    <description>Percentage of subjects with a gain of ≥ 15 letters using ETDRS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra- or subretinal fluid</measure>
    <time_frame>Week 24 and 52</time_frame>
    <description>Number of subjects without intra- or subretinal fluid (ie, completely dry)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Retinal pigment epithelium detachments</measure>
    <time_frame>Through study completion</time_frame>
    <description>Number of subjects with retinal pigment epithelium detachments</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systemic Ranibizumab concentrations</measure>
    <time_frame>Day 0, Day 1 and week 20</time_frame>
    <description>Systemic Ranibizumab concentrations</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">580</enrollment>
  <condition>Macular Degeneration</condition>
  <arm_group>
    <arm_group_label>Xlucane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Xlucane (0.05 mL of 10 mg/mL ranibizumab) in the study eye monthly for 52 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lucentis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lucentis (0.05 mL of 10 mg/mL ranibizumab) in the study eye monthly for 52 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Ranibizumab</intervention_name>
    <description>Intravitreal injection</description>
    <arm_group_label>Lucentis</arm_group_label>
    <arm_group_label>Xlucane</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written and signed informed consent form obtained at screening, before any
             study-related procedures.

          -  Willingness and ability to undertake all scheduled visits and assessments as judged by
             the investigator.

          -  Newly diagnosed, active subfoveal Choroidal Neovascularization (CNV) lesion secondary
             to age-related macular degeneration (AMD) in the study eye. Note: Active CNV indicates
             the presence of leakage as evidenced by Fluorescein Angiography (FA) and intra- or
             subretinal fluid as evidenced by Optical Coherence Tomography (OCT) which must be
             confirmed by the central reading center during Screening:

               1. The area of CNV must be ≥ 50% of the total lesion area in the study eye, and

               2. Total lesion area ≤ 9.0 Disc Areas (DA) in size (including blood, scars and
                  neovascularization) as assessed by FA in the study eye.

          -  Best Corrected Visual Acuity (BCVA) of ≤ 73 and ≥ 49 ETDRS letter score in the study
             eye, using ETDRS chart (20/40 to 20/100 Snellen equivalent) at Screening.

          -  Fellow eye should not be expected to need any anti-VEGF treatment for the duration of
             study participation.

          -  Age ≥ 50 years at screening.

          -  Male and female subjects of childbearing potential must be willing to completely
             abstain or agree to use an appropriate method of contraception, from the time of
             signing informed consent and for the duration of study participation through 3 months,
             following the last dose of study drug.

        Exclusion Criteria:

          -  Any previous intervention including pharmacological treatment, laser and/or surgery
             for wAMD in either eye; (Exception: Vitamin supplementation for AMD prevention).

          -  Any previous vitreoretinal surgery in the study eye for any cause.

          -  Any previous IVT treatment including any anti-VEGF medications, steroids and/or any
             other investigational medication in either eye.

          -  The use of long-acting steroids, either systemic or intraocular in any eye, in the 18
             months before planned initiation of study treatment. (Note: Iluvien® [fluocinolone
             acetonide intravitreal], current or planned implantation during the study, is
             prohibited.)

          -  Subfoveal fibrosis, atrophy or scarring extending &gt; 50% of total lesion area, in the
             study eye as assessed by the investigator at screening and confirmed by the central
             reading center prior to randomization.

          -  Choroidal neovascularization in either eye due to non-AMD causes (eg, DME, RVO, ocular
             histoplasmosis or trauma, etc.) as assessed by FA and confirmed by central reading
             center.

          -  Active or recent (within 28 days prior to randomization) intraocular, extraocular, and
             periocular inflammation or infection in either eye.

          -  History of idiopathic or autoimmune-associated uveitis in either eye.

          -  Infectious conjunctivitis, keratitis, scleritis or endophthalmitis in either eye.

          -  Unmedicated intraocular pressure (IOP) ≥ 30 mmHg at Screening in either eye.

          -  Topical ocular corticosteroids administered for ≥ 30 consecutive days in the study eye
             within 90 days prior to Screening.

          -  Spherical equivalent of the refractive error in the study eye demonstrating more than
             8 diopters of myopia.

          -  Corneal transplant or corneal dystrophy in the study eye.

          -  History of rhegmatogenous retinal detachment in the study eye.

          -  History of macular hole in the study eye.

          -  Retinal pigment epithelial tear or rip, involving the macula in the study eye as
             assessed by FA and confirmed by the central reading center.

          -  Current vitreous hemorrhage in the study eye.

          -  Subretinal hemorrhage that is ≥ 50% of the total lesion area in the study eye, or if
             the subretinal hemorrhage involves the fovea is 1 or more DA (≥ 2.54 mm2) in size in
             the study eye, as assessed by FA and confirmed by the central reading center.

          -  Other intraocular surgery (including cataract surgery) in the study eye within the 3
             months prior to baseline. The yttrium aluminum garnet [YAG] posterior capsulotomy is
             allowed not later than 4 weeks prior to screening.

          -  Any concurrent intraocular condition in the study eye (eg, cataract or diabetic
             retinopathy) that, in the opinion of the investigator, could require treatment during
             the study period to prevent or treat loss of visual acuity.

          -  Significant media opacities (including cataract) in the study eye interfering with
             BCVA assessment or fundus imaging (FA/FP/OCT).

          -  Aphakia or absence of the posterior capsule in the study eye, unless it occurred as a
             result of a YAG posterior capsulotomy in association with prior posterior chamber
             intraocular lens implantation.

          -  Presence of advanced glaucoma or optic neuropathy that involve(s) or threaten(s) the
             central visual field in the study eye (as judged by the investigator).

          -  History of glaucoma filtering surgery or argon laser trabeculoplasty in the study eye
             (Exception: Laser iridotomy and selective laser trabeculoplasty are allowed).

          -  Uncontrolled ocular glaucoma or hypertension in the study eye, defined as IOP ≥ 25
             mmHg despite treatment with anti-glaucoma medication.

          -  Any previous systemic anti-VEGF treatment (eg, bevacizumab).

          -  Contraindication for Lucentis® (hypersensitivity to ranibizumab or to any of the study
             treatment excipients).

          -  Current treatment for active systemic infection.

          -  Females who are pregnant, nursing, planning a pregnancy during the study, or of
             childbearing potential and not using a reliable method of contraception and/or not
             willing to use a reliable method of contraception during their participation in the
             study.

          -  Participation in another clinical trial within the previous 3 months or any other
             clinical trial of anti-angiogenic drugs.

          -  Reasonable suspicion of other disease or condition that might render the subject at a
             high risk of treatment complications or otherwise confound interpretation of the study
             results (as judged by the investigator).

          -  PK subgroup only: Contraindication for additional blood sampling (as judged by the
             investigator).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anat Loewenstein, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tel-Aviv Sourasky Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xbrane Biopharma</last_name>
    <phone>0046760346733</phone>
    <email>xbregistry@xbrane.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Retinal Research Institute, LLC</name>
      <address>
        <city>Gilbert</city>
        <state>Arizona</state>
        <zip>85296</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Arizona Retina and Vitreous Consultants</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85021-8880</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Retina Centers P.C</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85704-5611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Win Retina</name>
      <address>
        <city>Arcadia</city>
        <state>California</state>
        <zip>91006-3607</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Retina Partners</name>
      <address>
        <city>Encino</city>
        <state>California</state>
        <zip>91436-2018</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mark B. Kislinger MD Inc.</name>
      <address>
        <city>Glendora</city>
        <state>California</state>
        <zip>91741</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Retina Consultants Medical Group Inc.</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95819</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Colorado Retina Associates</name>
      <address>
        <city>Golden</city>
        <state>Colorado</state>
        <zip>80401-5069</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fort Lauderdale Eye Institute</name>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <zip>33324-3118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sarasota Retina Institute</name>
      <address>
        <city>Sarasota</city>
        <state>Florida</state>
        <zip>34239-7246</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Center for Retina and Macular Disease</name>
      <address>
        <city>Winter Haven</city>
        <state>Florida</state>
        <zip>33880-3919</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Southeast Retina Center</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30909-6440</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Georgia Retina</name>
      <address>
        <city>Marietta</city>
        <state>Georgia</state>
        <zip>30060</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Gailey Eye Clinic</name>
      <address>
        <city>Bloomington</city>
        <state>Illinois</state>
        <zip>61704</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sabates Eye Centers</name>
      <address>
        <city>Leawood</city>
        <state>Kansas</state>
        <zip>66211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Retina Vitreous Surgeons of Central New York PC</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>13224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Retina Associates of Western New York</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14620-4655</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Charleston Neuroscience Institute</name>
      <address>
        <city>Ladson</city>
        <state>South Carolina</state>
        <zip>29456</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Black Hills Regional Eye Institute</name>
      <address>
        <city>Rapid City</city>
        <state>South Dakota</state>
        <zip>57701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Retina Research Institute of Texas</name>
      <address>
        <city>Abilene</city>
        <state>Texas</state>
        <zip>79606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Austin Retina Associates</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705-1169</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Houston Eye Associates</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77025-1756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Retina Consultants of Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030-2727</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medical Center Ophthalmology Associates</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78240-1502</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Retina Consultants of Houston</name>
      <address>
        <city>The Woodlands</city>
        <state>Texas</state>
        <zip>77384</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Strategic Clinical Research Group LLC</name>
      <address>
        <city>Willow Park</city>
        <state>Texas</state>
        <zip>76087</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Specialized Eye hospital for active treatment Luxor</name>
      <address>
        <city>Plovdiv</city>
        <zip>4000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Specialized eye clinic Zrenie</name>
      <address>
        <city>Sofia</city>
        <zip>1408</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Specialized Eye hospital for active treatment Acad. Pashev</name>
      <address>
        <city>Sofia</city>
        <zip>1517</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Specialized Hospital for Active Treatment of Eye Diseases &quot;Zora&quot;</name>
      <address>
        <city>Sofia</city>
        <zip>1744</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>AMCSMP Eye Clinic St. Petka</name>
      <address>
        <city>Varna</city>
        <zip>9010</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Všeobecná FN v Praze</name>
      <address>
        <city>Brno</city>
        <zip>625 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Oční klinika, Fakultní nemocnice</name>
      <address>
        <city>Hradec Králové</city>
        <zip>50005</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Faculty Hospital Kralovske Vinohrady</name>
      <address>
        <city>Praha</city>
        <zip>10034</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>VFN Ocni klinika</name>
      <address>
        <city>Praha</city>
        <zip>12808</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Axon-Clinical, s.r.o.</name>
      <address>
        <city>Praha</city>
        <zip>15000</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mustame Eye Centre</name>
      <address>
        <city>Tallinn</city>
        <zip>13419</zip>
        <country>Estonia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>OÜ Dr Kai Noor Silmakabinet</name>
      <address>
        <city>Tallin</city>
        <zip>11412</zip>
        <country>Estonia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Magyar Honvédség Egészségügyi Központ</name>
      <address>
        <city>Budapest</city>
        <zip>1062</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Department of Ophthalmology, Semmelweis University</name>
      <address>
        <city>Budapest</city>
        <zip>1085</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Bajcsy-Zsilinszky Hospital</name>
      <address>
        <city>Budapest</city>
        <zip>1106</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Szent Imre Teaching Hospital</name>
      <address>
        <city>Budapest</city>
        <zip>1115</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Budapest Retina Associates</name>
      <address>
        <city>Budapest</city>
        <zip>1133</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Jahn Ferenc South-Budapest Hospital</name>
      <address>
        <city>Budapest</city>
        <zip>1204</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Debrecen</name>
      <address>
        <city>Debrecen</city>
        <zip>4032</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Szabolcs-Szatmr-Bereg County Hospital</name>
      <address>
        <city>Nyíregyháza</city>
        <zip>4400</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ganglion Medical Center</name>
      <address>
        <city>Pécs</city>
        <zip>7621</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Markusovszky University Teaching Hospital</name>
      <address>
        <city>Szombathely</city>
        <zip>9700</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Zalan Megyei Szent Rafael kórház</name>
      <address>
        <city>Zalaegerszeg</city>
        <zip>8900</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Rising Retina Clinic</name>
      <address>
        <city>Ahmedabad</city>
        <zip>380015</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Soroka University Medical Center</name>
      <address>
        <city>Beer Sheva</city>
        <zip>84101</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Bnai Zion Medical Center</name>
      <address>
        <city>Haifa</city>
        <zip>31048</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Rambam Health Care Campus</name>
      <address>
        <city>Haifa</city>
        <zip>3109601</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Carmel Medical Center</name>
      <address>
        <city>Haifa</city>
        <zip>3436212</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Shaare Zedek Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <zip>9103102</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hadassah University Hospital</name>
      <address>
        <city>Jerusalem</city>
        <zip>9112001</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Meir Medical Center</name>
      <address>
        <city>Kfar Saba</city>
        <zip>4428164</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Rabin Medical Center</name>
      <address>
        <city>Petah Tikva</city>
        <zip>49100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kaplan Medical Center</name>
      <address>
        <city>Reẖovot</city>
        <zip>7610001</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Tel Aviv Sourasky Medical Centre</name>
      <address>
        <city>Tel Aviv</city>
        <zip>64239</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Asaf Harofe Hospital</name>
      <address>
        <city>Zrifin</city>
        <zip>73000</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>P.Stradins University Hospital</name>
      <address>
        <city>Riga</city>
        <zip>1002</zip>
        <country>Latvia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Dr Solomatin Eye Center</name>
      <address>
        <city>Riga</city>
        <zip>1050</zip>
        <country>Latvia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital of Lithuanian University of Health Sciences Kauno klinikos</name>
      <address>
        <city>Kaunas</city>
        <zip>50161</zip>
        <country>Lithuania</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Vilnius University Hospital Santaros Klinikos</name>
      <address>
        <city>Vilnius</city>
        <zip>08661</zip>
        <country>Lithuania</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinika Okulistyczna Oftalmika</name>
      <address>
        <city>Bydgoszcz</city>
        <zip>85631</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Professor K. Gibinski University Clinical Centre</name>
      <address>
        <city>Katowice</city>
        <zip>40514</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Samodzielny Publiczny Szpital Kliniczny Nr 1 w Lublinie</name>
      <address>
        <city>Lublin</city>
        <zip>20079</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centrum Diagnostyki i Mikrochirurgii Oka LENS</name>
      <address>
        <city>Olsztyn</city>
        <zip>10424</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dr Nowosielska Okulistyka i Chirurgia Oka</name>
      <address>
        <city>Warszawa</city>
        <zip>01249</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Retina Okulistyka Sp. z o.o. sp. km</name>
      <address>
        <city>Warszawa</city>
        <zip>01364</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinica Retina</name>
      <address>
        <city>Bucharest</city>
        <zip>014142</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Opticlass Timisoara</name>
      <address>
        <city>Timişoara</city>
        <zip>300012</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>FGAU NMRC MNTK Eye Microsurgery n.a. acad. S.N. Fyodorov Cheboksary Branch</name>
      <address>
        <city>Cheboksary</city>
        <zip>428028</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>LLC Kuzlyar</name>
      <address>
        <city>Kazan</city>
        <zip>420066</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Federal State Budget Scientific Institute of Eye Diseases</name>
      <address>
        <city>Moscow</city>
        <zip>119021</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>S. Fyodorov Eye Microsurgery Federal State Institution</name>
      <address>
        <city>Moscow</city>
        <zip>127486</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>S.Fyodorov Eye Microsurgery Federal State Institution</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>192283</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>First Pavlov State Medical University of St.Petersburg</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>197022</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>F.D.Roosevelt Hospital</name>
      <address>
        <city>Banská Bystrica</city>
        <zip>97517</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Univerzitna nemocnica Bratislava, Nemocnica Ruzinov</name>
      <address>
        <city>Bratislava</city>
        <zip>82606</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fakultna nemocnica Trencin</name>
      <address>
        <city>Trenčín</city>
        <zip>91171</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fakultna nemocnica s poliklinikou Zilina</name>
      <address>
        <city>Žilina</city>
        <zip>1207</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario de Albacete</name>
      <address>
        <city>Albacete</city>
        <zip>2006</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Instituto de Microcirugia Ocular</name>
      <address>
        <city>Barcelona</city>
        <zip>8035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital de Viladecans</name>
      <address>
        <city>Barcelona</city>
        <zip>8840</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Bellvitge University Hospital</name>
      <address>
        <city>L'Hospitalet De Llobregat</city>
        <zip>8907</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Puerta de Hierro-Majadahonda</name>
      <address>
        <city>Madrid</city>
        <zip>02008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinica Universidad de Navarr</name>
      <address>
        <city>Pamplona</city>
        <zip>31008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital General de Catalunya</name>
      <address>
        <city>Sant Cugat Del Vallès</city>
        <zip>08195</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen Macarena</name>
      <address>
        <city>Sevilla</city>
        <zip>41009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Unit of Macula. Oftalvist Clinic</name>
      <address>
        <city>Valencia</city>
        <zip>46004</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>FISABIO-Oftalmologia Medica FOM</name>
      <address>
        <city>Valencia</city>
        <zip>46015</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Rio Hortega</name>
      <address>
        <city>Valladolid</city>
        <zip>47012</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario Lozano Blesa</name>
      <address>
        <city>Zaragoza</city>
        <zip>50009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Miguel Servet</name>
      <address>
        <city>Zaragoza</city>
        <zip>50009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Regional Clinical Hospital Center for Emergency Medical Care And Disaster Medicine</name>
      <address>
        <city>Kharkiv</city>
        <zip>61204</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medical and Diagnostic Centre PE PMC &quot;Acinus&quot;</name>
      <address>
        <city>Kropyvnytskyi</city>
        <zip>25006</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Filatov Institute of Eye Diseases Tissue Therapy</name>
      <address>
        <city>Odessa</city>
        <zip>65061</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinic of Professor Serhiienko</name>
      <address>
        <city>Vinnitsa</city>
        <zip>21000</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medical center LTD VISUS</name>
      <address>
        <city>Zaporizhzhia</city>
        <zip>69032</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Bulgaria</country>
    <country>Czechia</country>
    <country>Estonia</country>
    <country>Hungary</country>
    <country>India</country>
    <country>Israel</country>
    <country>Latvia</country>
    <country>Lithuania</country>
    <country>Poland</country>
    <country>Romania</country>
    <country>Russian Federation</country>
    <country>Slovakia</country>
    <country>Spain</country>
    <country>Ukraine</country>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>January 8, 2019</study_first_submitted>
  <study_first_submitted_qc>January 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 15, 2019</study_first_posted>
  <last_update_submitted>June 30, 2020</last_update_submitted>
  <last_update_submitted_qc>June 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Macular Degeneration</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ranibizumab</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

